All three independent proxy advisory firms issued recommendations in favor of Genesco Inc.'s nine-director slate, delivering institutional cover for the $500 million Nashville-based footwear retailer to rebuff activist shareholder Bradley Radoff ahead of its annual meeting. ISS, Glass Lewis, and Egan-Jones each published separate reports endorsing management's board composition and rejecting Radoff's challenge to seat alternative directors.

The unanimous advisory position matters because proxy firms collectively influence voting decisions for institutional holders managing roughly $40 trillion in assets under management. ISS alone guides approximately $25 trillion in voting decisions. When all three major firms align on a contested proxy, the statistical probability of activist success drops below 12 percent based on decade-long data from FactSet SharkWatch. Genesco's investor base includes Vanguard at 9.2 percent, BlackRock at 8.7 percent, and Dimensional Fund Advisors at 6.3 percent, all of which typically follow ISS guidance absent material conflicts.

Radoff's challenge centered on portfolio underperformance and capital allocation decisions at Genesco, which operates 1,425 retail locations across the Journeys, Johnston & Murphy, and Schuh nameplates. The activist argued for accelerated store rationalization and a pivot toward digital-first distribution. Genesco shares traded at $28.40 when Radoff disclosed his stake in February; they closed at $31.15 the session before ISS released its report. The company's management highlighted 18 percent year-over-year digital revenue growth and margin expansion in its defense materials, arguing the transformation timeline Radoff proposed would destroy rather than unlock value in a capital-intensive retail format.

The proxy advisors' endorsement removes the primary uncertainty overhanging Genesco equity into the June 12 annual meeting. Activist campaigns that lose ISS support rarely recover sufficient institutional votes to prevail, and losing all three major firms has historically resulted in vote margins exceeding 70-30 in favor of management. For allocators holding Genesco in small-cap value or special-situations sleeves, the removal of governance risk clarifies the investment case back to operational execution and footwear category health. The company's forward price-to-earnings multiple of 8.2x on consensus fiscal 2026 estimates now trades without the governance discount that appeared in February.

Watch for Radoff's response in the 10-day window following ISS publication—historically, activists either withdraw or double down with supplemental materials questioning advisor methodology. Genesco's preliminary vote count will surface in 8-K filings within four business days of the June meeting. The company has guided fiscal 2025 comparable-store sales growth of 2-4 percent and operating margin of 6.5-7.0 percent, metrics that will either validate the board's strategy or provide Radoff ammunition for a second campaign in calendar 2026.

Genesco's annual meeting occurs June 12 in Nashville. The company will report fourth-quarter fiscal 2025 earnings March 20, three weeks before the proxy record date closes.